Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Access Pharmaceuticals has reported that current chairman Jeffrey Davis has been appointed to the additional role of CEO.
Subscribe to our email newsletter
Stephen Seiler has resigned as president and CEO of the company for health reasons. Mr. Seiler has also resigned from the board of directors.
Mr. Davis said: “I am excited about Access’s prospects in 2008 and beyond and look forward to working with the organization to build on recent achievements.”